- INTRODUCTION :
Insider trading means dealing in securities of a company by its directors, employees or other insiders based on Unpublished Price Sensitive Information. Such dealing by insiders erodes the investors’ confidence in the integrity of the management and is unhealthy for the capital markets.
Insider trading is not only unethical and immoral but also illegal as it fuels illegitimate speculation in the share prices on the Stock Exchanges. Such a profiteering by insiders by misusing confidential information available to them by virtue of their position or connection with the Company erodes investors’ confidence in the integrity of the management of a company and adversely impacts the capital markets.
The Securities and Exchange Board of India (SEBI), in its endeavor to protect the interests of the investors in general, had formulated the SEBI (Prohibition of Insider Trading) Regulations, 2015 (“Regulations”), to be effective from 15th May, 2015.
Accordingly, the Samrat Insider Trading Policy (“Code”) are formulated to regulate procedures for fair disclosure of Unpublished Price Sensitive Information, monitor and report trading by its employees and other connected persons , towards achieving compliance with the Regulations,
This Code is based on the principle that Designated Person of a Company owes a fiduciary duty to the shareholders of the Company and should place the interest of the shareholders above their own by conducting their personal securities transactions in a manner that does not create any conflict of interest. This Code is also intended to serve as a guiding charter for all concerned persons associated with the functioning of the company and their dealings in securities. Further, the Code also seeks to ensure timely and adequate disclosure of price sensitive information to the investors by the Company so as to enable them to take informed investment decisions with regard to the Company’s securities.
2. APPLICABILITY :
This Code is applicable on all employees and other connected persons who have access to or could have access to unpublished price sensitive information about the Company. Such persons are required to comply and make the necessary disclosures as required under this Code. This Code shall be applicable with effect from 15 May, 2015.
3. DEFINITIONS :
In this code, unless the context otherwise requires, the following words, expressions and derivations there from shall have the meanings assigned to them as under:–
a. “Act” means the Securities and Exchange Board of India Act, 1992.
b. “Board of Directors” means the Board of Directors of Samrat Pharmachem Limited.
c. “Code” shall mean the Samrat Insider Trading Policy as amended from time to time.
d. “Company” means Samrat Pharmachem Limited or SPL.
e. “Compliance Officer” means Company Secretary designated so and reporting to the Board, who shall be responsible for compliance of policies, procedures, maintenance of records, monitoring adherence to the rules for the preservation of Unpublished Price Sensitive Information, monitoring of trades and the implementation of the Code specified in the Regulations under the overall supervision of the Board of the Company.
f. “Connected Person” means.
i. Any person who is or has during the six months prior to the concerned act been associated with a company, directly or indirectly, in any capacity including by reason of frequent communication with its officers or by being in any contractual, fiduciary or employment relationship or by being a director, officer or an employee of the Company or holds any position including a professional or business relationship between himself and the Company whether temporary or permanent, that allows such person, directly or indirectly, access to Unpublished Price Sensitive Information or is reasonably expected to allow such access.
ii. Without prejudice to the generality of the foregoing, the persons falling within the following categories shall be deemed to be connected persons unless the contrary is established:
a. An immediate relative of connected persons specified in clause (i); or
b. A holding company or associate company or subsidiary company; or
c. An intermediary as specified in Section 12 of the Act or an employee or director thereof; or
d. An investment company, trustee company, asset management company or an employee or director thereof; or
e. An official of a stock exchange or of clearing house or corporation; or
f. A member of board of trustees of a mutual fund or a member of the board of directors of the asset management company of a mutual fund or is an employee thereof; or
g. A member of the Board of directors or an employee, of a public financial institution as defined in section 2 (72) of the Companies Act, 2013; or
h. An official or an employee of a self-regulatory organization recognized or authorized by the Board; or
i. A banker of the Company; or
j. A concern, Firm, Trust, Hindu Undivided Family, Company or Association of Persons wherein a Director of the Company or his immediate relative or banker of the Company, has more than ten per cent, of the holding or interest.
g. “Dealing in Securities” means an act of subscribing to, buying, selling or agreeing to subscribe, buy, sell or deal in the securities of the Company either as principal or agent.
h. “Designated Persons” means :
i. Directors of the Company;
ii. Key Managerial Personnel (KMP’s) as per Companies Act, 2013
iii. All the employees of Samrat Pharmachem Limited in the cadre of Vice-President and above and all the employees of the Finance and the Secretarial Departments of Samrat Pharmachem Limited.
iv. Promoters/Promoter Group of the Company.
v. Any other employee of the Company including employees of Subsidiary Companies/ Associates
companies as may be determined and informed by the Compliance Officer from time to time
vi. Persons in contractual, fiduciary or advisory relationship with the Company i.e. consultants, retainers, auditors, law firms, analysts etc.
vii. Immediate relatives of persons covered under clause (i) to (vi) above.
i. “Director” means a member of the Board of Directors of the Company.
j. “Employee” means every employee of the Company including the Directors in the employment of the Company.
k. “Generally available Information” means information that is accessible to the public on a nondiscriminatory basis.
l. “Immediate Relative” means a spouse of a person, and includes parent, sibling, and child of such person or of the spouse, any of whom is either dependent financially on such person, or consults such person in taking decisions relating to trading in securities.
m. “Insider” means any person who is:
i) A connected person; or
ii) In possession of or having access to Unpublished Price Sensitive Information
3.14“Key Managerial Person” means person as defined in Section 2(51) of the Companies Act, 2013.
3.15“Promoter” shall have the meaning assigned to it under the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 or any modification thereof.
3.16 “Regulations” shall mean the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and any amendments thereto.
3.17 “Securities” shall have the meaning assigned to it under the Securities Contracts (Regulation) Act,
1956 (42 of 1956) or any modification thereof except units of a mutual fund.
3.18 “Takeover Regulations” means the Securities and Exchange Board of India (Substantial Acquisition of
Shares and Takeovers) Regulations, 2011 and any amendments thereto;
3.19 “Trading” means and includes subscribing, buying, selling, dealing, or agreeing to subscribe, buy, sell,
deal in any securities, and “trade” shall be construed accordingly.
3.20 “Trading Day” means a day on which the recognized stock exchanges are open for trading.
3.21 “Trading Window” means a trading period for trading in Company’s securities as specified by the
Company from time to time.
3.22 “Unpublished Price Sensitive Information”: means any information, relating to Company or its
securities, directly or indirectly, that is not generally available which upon becoming generally available, is likely to materially affect the price of the securities and shall, ordinarily including but not restricted to, information relating to the following:
i) Financial results;
iii) Change in capital structure;
iv) Mergers, de-mergers, acquisitions, delisting, disposals and expansion of business and such other transactions;
v) Changes in key managerial personnel; and
vi) Material events in accordance with the listing agreement
The words and expressions used and not defined in these regulations but defined in the Securities and Exchange Board of India Act, 1992 (15 of 1992), the Securities Contracts (Regulation) Act, 1956 (42 of 1956), the Depositories Act, 1996 (22 of 1996) or the Companies Act, 2013 (18 of 2013) and rules and regulations made thereunder shall have the meanings respectively assigned to them in those legislation(s)
4. CODE :
a. PRESERVATION OF “UNPUBLISHED PRICE SENSITIVE INFORMATION” AND PROHIBITION TO DEAL/BUY/SELL/PLEDGE ETC SECURITIES OF THE COMPANY BY INSIDERS
i. The insiders shall maintain the confidentiality of all Unpublished Price Sensitive Information and shall not pass on such information to any person directly or indirectly by way of making a recommendation for the Dealing, purchase or sale of securities.
4.1.2 The insiders when in possession of any unpublished price sensitive information pertaining to the Company shall not:
(a) Deal/Buy/sell securities of the Company, either on their own behalf or on behalf of any other person.
(b) Communicate, counsel or procure any unpublished price sensitive information to/ from any person.
b. NEED TO KNOW
Unpublished Price Sensitive Information is to be handled on a “need to know” basis i.e. Unpublished Price Sensitive Information should be disclosed only to those within the Company who need the information to discharge their official dutiesand whose possession of Unpublished Price Sensitive Information will not in any manner give rise to a conflict of interest or likelihood of misuse of the information.
c. LIMITED ACCESS TO CONFIDENTIAL INFORMATION
Files containing confidential information shall be kept secure. Computer files must have adequate security of login and password etc.
d. RESTRICTION TO DEAL/ BUY / SELL/ PLEDGE ETC SECURITIES
i. The Designated Persons shall not deal/ buy/sell/ pledge etc securities of the Company during Closure of the ‘Trading Window’, i.e. the period during which trading in the securities of the Company is prohibited. The Designated persons shall conduct all their dealings in the securities of the Company only during an open trading window and shall not deal in any transaction involving the purchase/ sale/ pledge etc of the Company’s securities during the periods when the trading window is closed.
4.4.2 The closure of trading Window for the purposes for which a specific notice/ intimation is required to be given to Stock Exchange shall commence SEVEN DAYS before the date of Board meeting for consideration of any Unpublished Price Sensitive Information . However, if the circumstances so warrants, the time for closing of trading window may be increased or decreased by the Compliance Officer.
The Trading Window shall be opened on third calendar day from the day on which the Price sensitive information is communicated to the Stock Exchange and becomes generally available.
4.4.3 The closure of the trading window for the purposes for which no specific notice/ intimation is required to be given to Stock Exchange shall be advised by the Compliance Officer of the Company, while the Trading Window shall be opened on third calendar day from the day on which Price sensitive information is communicated to the Stock Exchange and becomes generally available.
4.4.4 In case of ESOPs, exercise of option may be allowed in the period when the trading window is closed. However, sale/pledge of shares allotted in exercise of ESOPs shall not be allowed when trading window is closed.
4.4.5 Designated Persons who deal, buy or sell any number of shares of the Company, shall not enter into an opposite transaction i.e. sell or buy any number of shares during the next six months following the prior transaction. However, the Compliance Officer(s) is empowered to grant relaxation from strict application of such restriction for reasons to be recorded in writing provided that such relaxation does not violate these regulations. If a contra trade be executed, inadvertently or otherwise, in violation of such a restriction, the profits from such trade shall be liable to be disgorged for remittance to the SEBI for credit to the Investor Protection and Education Fund administered by the SEBI under the Act. The application for this approval should be made to the Compliance Officer(s) in format specified in Annexure I.
4.4.6 All Designated persons, who intend to deal in Company’s securities (themselves or through immediate relatives) during the period other than trading window closure, are required to obtain the pre-clearance of the proposed acquisition/purchase/ sale/pledge transactions as per the procedure described hereunder, if the said transaction of the securities of Company is in excess of 25,000 in number in a single day. In case of dealing by Compliance Officer(s), pre-clearance from Managing Director shall be required. An application stating, inter alia, the estimated number of securities that the Designated Person intends to deal in, the details as to the depository with which he has security account and the details as to the securities already held etc, for pre-clearance shall be made to the Compliance Officer of Company in the format specified in Annexure I. An undertaking shall also be executed in favour of the Company by such Designated Person incorporating, inter alia, the following clauses, as may be applicable:
a) That the said Designated Person or his immediate relative does not have any access or has not received “Price Sensitive Information” upto the time of signing the undertaking.
b) That in case the said Designated Person or his immediate relative has access to or receives “Price Sensitive Information” after signing of the undertaking but before the execution of the transaction he/she shall inform the Compliance Officer(s) of the change in his position and that he/she would completely refrain from dealing in the securities of the Company till the time such information becomes public.
c) That he/she has not contravened the code of conduct for prevention of insider trading as notified by the company from time to time.
d) That he/she has made a full and true disclosure in the matter.
4.4.7 The Compliance Officer(s) will scrutinize the application within 2 working days of submission and communicate the approval/ refusal (along with reasons therefore) to the applicant. In the absence of the Compliance Officer(s), the preclearance application will be decided upon by the Managing Director.
4.4.8 In case any transaction has been refused, the Designated Person shall be free to re-apply for pre-clearance of the transaction, which was refused, to Chairman of Audit Committee of the Company. The decision of Chairman of Audit Committee in this regard shall be final.
4.4.9 The pre-clearance approval shall be valid only for seven calendar days from the date of communication and shall lapse thereafter. If the transaction is not consummated within seven calendar days from the approval date, the Designated Person will be required to follow the process of pre clearance again. However the Compliance Officer(s) shall have the right to revoke the clearance granted, before the relevant transaction has been consummated, if considered necessary.
4.4.10 The requirements of pre- clearance of a proposed transaction shall not apply in the following cases:
a. In the event of participation of a public event i.e. a rights or a bonus issue.
b. In the case of any acquisition of shares through transmission or inheritance, or like mode.
c. By way of any court settlement or award thereof.
e. TRADING PLAN
i. The Designated Persons, who are perpetually in possession of unpublished price sensitive information, shall have an option to formulate their trading plan and present the same to Compliance Officer(s) for approval. Upon approval of Trading Plan, the Compliance Officer(s) shall notify the same to Stock Exchanges where securities of the Company are listed. The Compliance Officer(s) shall review the trading plan to assess whether the plan would have any potential for violation of these regulations and may seek such express undertakings as may be necessary to enable such assessment and to approve and monitor the implementation of the plan.
The Trading plan shall comply with following requirements:
a) Trading/Dealing in securities will commence after six months of public disclosure of trading plan.
b) No Trading/Dealing between SEVEN (07) trading days prior to last day of any financial period for which results are required to be announced and till THIRD (03) trading day after disclosure of financial results.
c) Trading plan should be for a period of at least 12 months and there should not be any time overlapping in two trading plans.
d) Trading plan shall set out number of securities to be traded along with the nature of trade and the intervals at or the dates on which such trades shall be effected.
e) The Trading should not entail/result in market abuse.
f) The trading plan once approved shall be irrevocable & the insider shall mandatorily have to implement the plan, without being entitled to either deviate from it or to execute any trade in the securities outside the scope of the trading plan.
However, the implementation of the trading plan shall not be commenced if any unpublished price sensitive information in possession of the insider at the time of formulation of the plan has not become generally available at the time of the commencement of implementation and in such event the Compliance Officer shall confirm that the commencement ought to be deferred until such unpublished price sensitive information becomes generally available information.
4.6.1 By Designated Persons
Designated Persons shall make the following disclosures of shares and other securities held in the Company by them and their dependent family members, to the Compliance Officer:
|Periodicity of Disclosure||Disclosure Requirement||Time period within which disclosure is to be made|
|Initial Disclosure by Promoter, KMP and Director(s) of the Company||Number of Securities held by them as on May 15, 2015.||a) Within thirty (30) days of coming into effect of SEBI (Prohibition of Insider Trading) Regulations, 2015.b) Within seven (7) days of such appointment or becoming a promoter|
|Annual Disclosure by Promoter, employee and Director(s) of the Company||Number of Securities held by them.||Within 30 days of closing of Financial Year|
|Continual Disclosure by Promoter, Employee and Director of the Company, if the number of securities acquired or disposed of, if the value of securities traded individually or cumulatively during a calendar quarter exceeds ————. For the purpose of continual disclosure as specified above, the disclosure of the incremental transactions after any disclosure under this sub-regulation shall be made when the transactions effected after the prior disclosure cross the threshold specified of ——— during a calendar quarter.||Number of Securities or voting rights acquired or disposed off by them.||Within 2 trading days of dealing/acquisition/sale/transfer of securities.|
|Company shall notify these disclosures within two (2) trading days of receipt of such disclosure or becoming aware of such information to Stock Exchanges where the shares of the Company are listed|
4.6.2 Fair Disclosure of Unpublished Price Sensitive Information
22.214.171.124 Prompt public disclosure of Unpublished Price Sensitive Information that would impact price discovery no sooner than credible and concrete information comes into being in order to make such information generally available.
126.96.36.199 Uniform and universal dissemination of Unpublished Price Sensitive Information to avoid selective disclosure.
188.8.131.52 Compliance Officer is an officer of the Company who is designated to deal with dissemination of information and disclosure of Unpublished Price Sensitive Information.
184.108.40.206 Prompt dissemination of Unpublished Price Sensitive Information that gets disclosed selectively, inadvertently or otherwise to make such information generally available.
220.127.116.11 Appropriate and fair response to queries on news reports and requests for verification of market rumours by regulatory authorities.
18.104.22.168 Ensuring that information shared with analysts and research personnel is not Unpublished Price Sensitive Information.
22.214.171.124 Developing best practices to make transcripts or records of proceedings of meetings with analysts and other investor relations conferences on the official website i.e. www.lancogroup.com to ensure official confirmation and documentation of disclosures made.
126.96.36.199 Handling of all Unpublished Price Sensitive Information on a need-to-know basis.
a. In case it is observed by the Company/Compliance Officer(s) that there has been a violation of SEBI (Prohibition of Insider Trading) Regulations, 2015, SEBI shall be informed by the Company.
b. Designated Persons are advised to pursue this Code and Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, carefully and acquaint themselves with all the provisions contained therein. The Compliance Officer(s) shall assist the Designated Persons in addressing any clarifications regarding the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for Prevention of Insider Trading.
5.3 The Compliance Officer(s) shall be responsible for setting forth policies, procedures, monitoring adherence to the rules for the preservation of “Price Sensitive Information”, pre-clearing of trades by designating employees or their immediate relatives and the implementation of the Code of Conduct for Prevention of Insider Trading under the overall supervision of the Board of the listed company.
5.4 The Compliance officer(s) shall maintain records of all the declarations or information in the appropriate form given by the designated persons for a minimum period of five years.
5.5 The Compliance officer(s) shall place before the Chairman of the Audit Committee, on a quarterly basis all the details of the dealing in the securities by Designated Persons and the accompanying documents that such persons had executed the pre-dealing procedure as envisaged in this code.
Any contravention of the code by Designated Persons shall attract strictest disciplinary action including but not restricted to recovery of profits made, wage freeze, suspension and/ or termination of employment.
The Compliance Officer
Samrat Pharmachem Limited
Plot No.A2.3445, GIDC, Phase 4,
Sub: Application for Pre-clearance of Trade
I intend to deal in the Securities of Company. Detailed particulars of Proposed Transaction are as follows:
2. Designation, Department & Employee Code:
3. DPID-Client Id & Details of Depository:
4. Name(s) of Account Holder(s):
5. Relation with Designated Employee:
6. No of securities held (including those held by immediate relatives) before proposed transaction:
7. Nature of Proposed Transaction:
8. Estimated number of securities to be dealt in proposed Transaction (including by immediate relatives):
9. Estimated value of securities to be dealt in proposed Transaction (including by immediate relatives):
10. Reason for proposed Transaction:
You are requested to pre-clear the above transaction.